XBiotech Inc. (XBIT)

NASDAQ

$2,29

$+0,02

(+1,06%)

Pre-Market

XBiotech Inc. (XBIT) Live Price Chart

Last updated: ⁦2026-10-13 10:25:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

XBiotech Inc. (XBIT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2,29, with a market capitalisation of $69,82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,09 to $3,44. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$69,82M
Open	$2,27
Day's High	$32,50
Day's Low	$2,09
Previous Close	$2,29
Volume	--
Average Volume	40,45K
P/E Ratio	--
52-Week High	$3,44
52-Week Low	$2,09
Dividend Yield	--
Earnings Date	--

XBiotech Inc. (XBIT) Pre-Market Stock Price

XBiotech Inc. (XBIT) is trading at $2,29 in pre-market trading as of 2026-10-13 08:10:00, up 0,17% ($0,00) from the previous close of $2,29

Pre-market trading shows how investors are pricing XBIT before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

XBiotech Inc. (XBIT) 7-Day Stock Price Change

Over the past seven days, XBiotech Inc. (XBIT) moved from $2,19 to $2,29, representing a gain of 4,75% ($0,10).

The stock traded between $2,15 and $2,33 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 44,73 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

XBIT 52-Week Price Position

Position in Range: 15,1%

52W Low$2,09

52W High$3,44

XBIT is currently trading at $2,29, placing it 15,1% of the way from its 52-week low of $2,09 to its 52-week high of $3,44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is XBiotech Inc. (XBIT)?

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

XBiotech Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	87
Exchange	NASDAQ
Company Website	http://www.xbiotech.com

How to Buy XBiotech Inc. (XBIT) Stock on MEXC

Eligible investors can buy real shares of XBiotech Inc. (XBIT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XBIT and Place Your Order

Open the RealStocks trading page and search for XBIT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is XBiotech Inc. (XBIT) stock price today?

XBiotech Inc. (XBIT) is currently trading at $ 2,29, up 0,17% ($0,00) from the previous close of $ 2,29. Intraday prices update in real time during regular trading hours.

2.Is XBIT stock going up or down today?

As of 2026-10-13 08:10:00, XBIT is trading at $ 2,29, up 0,17% ($0,00) from its previous close of $ 2,29. The stock has traded between $ 2,09 and $ 32,50 during today’s regular session. Past price movements do not guarantee future results.

3.What is XBIT pre-market price?

As of 2026-10-13 08:10:00, XBIT is trading at $ 2,29 in pre-market trading, up 0,17% ($0,00) from the previous close of $ 2,29. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XBIT after-hours price?

As of 2026-10-13 08:10:00, XBIT is trading at $ 2,27 in after-hours trading, down 1,09% ($0,02) from the regular-session close of $ 2,29. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XBIT stock trading now?

XBIT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XBIT sit relative to its 52-week high and low?

Over the past 52 weeks, XBIT has traded between a low of $ 2,09 and a high of $ 3,44. At $ 2,29, the stock is positioned 15,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is XBiotech Inc. in?

XBiotech Inc. (XBIT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is XBiotech Inc.'s market capitalisation and where is it listed?

XBiotech Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 69,82M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XBIT valued in terms of P/E ratio and EPS?

XBIT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1,48. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does XBiotech Inc. pay a dividend?

XBiotech Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.